What does Molecule Holdings Inc. do?

Molecule Holdings Inc. (EVRRF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is EVRRF's market cap?

Molecule Holdings Inc. (EVRRF) has a market capitalization of approximately $626,130, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does EVRRF pay a dividend?

No — Molecule Holdings Inc. (EVRRF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Molecule Holdings Inc. (EVRRF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

EVRRF

Molecule Holdings Inc.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$626.13K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.57%CAGR −66.40%

Select date range

FromTo

Sep 22, 2020Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

EVRRF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 16

Last Report DateOct 23

Reported vs Estimate−$0.01

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$1.78M

Net Income−C$3.83M

Net Margin−215.1%

Operating Cash Flow−C$98.67K

Capital ExpendituresC$5.46

Free Cash Flow−C$98.67K

Return on Equity—

Return on Invested Capital−118.6%

Net DebtC$5.69M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for EVRRF and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how EVRRF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EVRRF and 80,000+ other tickers.

About Molecule Holdings Inc.

Molecule Holdings Inc. specializes in the Canadian production and contract packaging of cannabis-infused drinks. The company markets its range of beverages under brand names such as PHRESH, embody, and CANAJO. Its operational base is located in Lansdowne, Canada.

CEO: David Reingold
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 13
Website: www.molecule.ca

Peers

Isracann Biosciences Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About EVRRF

What does Molecule Holdings Inc. do?: Molecule Holdings Inc. (EVRRF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is EVRRF's market cap?: Molecule Holdings Inc. (EVRRF) has a market capitalization of approximately $626,130, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does EVRRF pay a dividend?: No — Molecule Holdings Inc. (EVRRF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is EVRRF profitable?: Molecule Holdings Inc. (EVRRF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.